511TiPA phase I, open-label study of GSK1795091 administered in combination with immunotherapies in participants with advanced solid tumours (NCT03447314)
Hansen, A R, Strauss, J, Chaves, J, Piha-Paul, S A, Park, H, Garralda, E, Matheny, C J, Carver, J, Moore, A, Hug, B AVolume:
30
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdz244.073
Date:
October, 2019
File:
PDF, 80 KB
english, 2019
File converter
More search results
More benefits 
